Sun Pharmaceutical Industries Sustainability Profile
Sun Pharmaceutical Industries Ltd., commonly known as Sun Pharma, is a leading global pharmaceutical company headquartered in India. Established in 1993, the company has grown to become one of the largest specialty generic pharmaceutical manufacturers in the world, with a strong presence in North America, Europe, and emerging markets. Sun Pharma focuses on a diverse range of therapeutic areas, including cardiology, psychiatry, neurology, and dermatology. Its core products encompass a wide array of generic medications, specialty pharmaceuticals, and over-the-counter products, distinguished by their high quality and affordability. The company has achieved significant milestones, including numerous product approvals and a robust pipeline of innovative therapies. With a commitment to research and development, Sun Pharma has positioned itself as a key player in the global pharmaceutical landscape, recognised for its excellence in manufacturing and a strong market presence.
DitchCarbon Score
How does Sun Pharmaceutical Industries's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sun Pharmaceutical Industries's score of 47 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sun Pharmaceutical Industries's reported carbon emissions
In 2025, Sun Pharmaceutical Industries reported total carbon emissions of approximately 392.3 million kg CO2e, comprising 156.2 million kg CO2e from Scope 1 and 236.1 million kg CO2e from Scope 2 emissions. The company has not disclosed Scope 3 emissions data for this year. Sun Pharmaceutical has set an ambitious target to achieve a 35% reduction in its Scope 1 and Scope 2 emissions by 2030, using 2020 as the baseline year. This commitment reflects the company's proactive approach to addressing climate change and reducing its carbon footprint. In 2023, the total emissions were approximately 777.1 million kg CO2e, with Scope 1 emissions at 67.2 million kg CO2e, Scope 2 at 352.7 million kg CO2e, and Scope 3 at 357.3 million kg CO2e. The company has consistently reported its emissions data, demonstrating transparency and accountability in its sustainability efforts. Overall, Sun Pharmaceutical Industries is focused on reducing its carbon emissions significantly, aligning with global climate goals and contributing to a more sustainable future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 77,616,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 377,728,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | - | - |
How Carbon Intensive is Sun Pharmaceutical Industries's Industry?
How Carbon Intensive is Sun Pharmaceutical Industries's Location?
Sun Pharmaceutical Industries's Scope 3 Categories Breakdown
A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 46% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 51% of Scope 3 emissions.
Top Scope 3 Categories
Sun Pharmaceutical Industries's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sun Pharmaceutical Industries has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
